Last reviewed · How we verify
NCT04888533: EHSSA
Efficient, Holistic, Heuristic and Semi-structured Suicide Assessment Tool (EHSSA) - Very Accurate Prediction of Risk.
trial testing EHSSA- An Efficient and Holistic/Heuristic Semi-structured Suicide Assessment Tool in Suicide Risk in 1,505 participants. Completed in 31 January 2020.
31 January 2020
Quick facts
| Lead sponsor | Care Plus NJ, Inc. |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 1,505 |
| Start date | 1 August 2019 |
| Primary completion | 31 January 2020 |
| Estimated completion | 31 January 2020 |
| Sites | 1 location across United States |
Drugs / interventions tested
- EHSSA- An Efficient and Holistic/Heuristic Semi-structured Suicide Assessment Tool
Conditions studied
- Suicide Risk — all drugs for Suicide Risk →
Sponsor
Care Plus NJ, Inc.
Who can join
Eligibility, any sex, with Suicide Risk. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Many studies have found that insights regarding suicide risk-factors for cohorts does not translate to practical value in the identification of such risk in specific individuals. E.H.S.S.A. - a suicide assessment tool that was empirically designed by an emergency psychiatry department (P.E.S.P. of Bergen County) in its effort to accurately predict, in specific patients, the risk of suicide attempts in the reasonably foreseeable future. It is of a unique paradigm that combines critical elements of holism, heuristics and semi-structured design.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04888533
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Suicide Risk
Currently open trials in the same condition.
- NCT06854224 — Orexin Antagonism for Suicide Risk: A Proof-of-Concept Clinical Trial · Phase 2 · recruiting
- NCT06564948 — Treatment for Individuals Interacting with the Criminal Justice System · NA · recruiting
- NCT04877977 — Long-term Observation of Participants With Mood Disorders · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04888533 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Care Plus NJ, Inc.
- Last refreshed: 1 June 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04888533.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing